We show that SD patients exhibit a significant increase of CD45RO+CCR6+CD4+ cells and of IL-17+ cells, both in TME and blood, as compared to NSND patients and healthy donors, independently from the tumor stage, alongside with a significant higher level of IL-6, in both blood and tumor culture supernatants. The gene discussed is IL17A; the disease is Salla disease.